Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
PEPFAR Scientific Advisory Board recommends accelerating scale up of HIV treatment

The Scientific Advisory Board (SAB) of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program met in September to discuss the results of the HIV Prevention Trials Network (HPTN) 052 trial. The 052 subcommittee made a list of six recommendations to U.S. Global AIDS Ambassador Eric Goosby and the Office of the Global AIDS Coordinator that the full board approved, with the first four listed in order of priority as defined by the SAB.

Published
17 November 2011
From
Science Speaks
What it means to be an HIV positive couple with a positive child

I am Innocent Bitandema, a 41-year-old peasant. I am married to Gloria Ahimbisibwe, a housewife aged 35 with four children. In 2004, I started coughing and I had on and off fever. When the cough became profuse, I went to the health centre where I was diagnosed with tuberculosis (TB). go →

Published
16 November 2011
From
Key Correspondents
New Six-Way Agreement Among Pharmas and NGOs will Speed Development of TB Drug Combinations

The Critical Path to TB Drug Regimens (CPTR) today announced an innovative agreement between AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization to share information on tuberculosis (TB) compounds within their respective drug pipelines to quickly identify and work together to develop the most promising TB drug regimen, regardless of sponsor.

Published
10 November 2011
From
Critical Path to TB Drug Regimens
Tuberculosis breakthrough as scientists get funds for 'electronic nose'

A team of Indian researchers are planning to have a prototype of an "electronic nose" that can detect tuberculosis from a person's breath in hospitals by October 2013, after receiving a $950,000 grant on Monday.

Published
08 November 2011
From
The Guardian
Poor adherence not enough to cause development of MDR-TB

Poor adherence may not be enough to cause multidrug-resistant tuberculosis, a laboratory study published in the online edition of the Journal of Infectious Diseases suggests. Moreover, the failure

Published
08 November 2011
By
Michael Carter
Screening and treatment removes TB as additional punishment in prisons

Innovative tuberculosis control programmes in prisons have reduced the prevalence of TB, and successfully provided isoniazid preventive therapy and treatment for both drug-sensitive and drug-resistant TB, researchers reported

Published
07 November 2011
By
Lesley Odendal
Funding for TB research and development declining

Funding levels for tuberculosis (TB) research and development (R &D) fell by 0.3% in 2010 compared to 2009, according to new data released by the Treatment Action

Published
07 November 2011
By
Lesley Odendal
An intensive household counselling intervention reduces the burden of TB in ZAMSTAR study

An intensive ‘household counselling’ intervention (involving TB contact tracing, multiple home visits, TB & HIV counselling and screening with linkages to care) reduced the prevalence of culture

Published
02 November 2011
By
Theo Smart
NanoLogix Technology Delivers Live Tuberculosis (TB) Detection Results in a Revolutionary 4 Days versus Traditional 21 Days

Third Party Research Study Results Are 500% Faster Than Conventional Tests

Published
02 November 2011
From
Business Wire (press release)
New TB roadmap emphasizes critical role of research

“Elimination of tuberculosis (TB) is more than an aspiration. We know it could become a reality, but this will happen only if we achieve radical transformation in the way TB is diagnosed, treated and prevented. This goal can be realized only if TB research is intensified and envisioned in an entirely new way.”

Published
02 November 2011
From
Tuberculosis Vaccine Initiative (TBVI)

Filter by country